Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.34)
# 4,006
Out of 4,784 analysts
24
Total ratings
26.67%
Success rate
-28.8%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $33.65 | +72.36% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $6.45 | +303.10% | 2 | Mar 13, 2025 | |
| ZYXI Zynex | Downgrades: Neutral | n/a | $2.25 | - | 2 | Mar 12, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $0.98 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $1.48 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $4.04 | +1,063.37% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $2.75 | +13,100.00% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.61 | +5,490.06% | 1 | Aug 4, 2022 | |
| HROW Harrow | Initiates: Buy | $14 | $26.21 | -45.63% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.70 | +311.76% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $5.23 | +894.26% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $551,250 | $1.56 | +35,336,438.46% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $6.49 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $58.85 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $33.65
Upside: +72.36%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $6.45
Upside: +303.10%
Zynex
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.25
Upside: -
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.98
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.48
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $4.04
Upside: +1,063.37%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $2.75
Upside: +13,100.00%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.61
Upside: +5,490.06%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $26.21
Upside: -45.63%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.70
Upside: +311.76%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $5.23
Upside: +894.26%
Jun 26, 2020
Initiates: Buy
Price Target: $551,250
Current: $1.56
Upside: +35,336,438.46%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $6.49
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $58.85
Upside: -